Radek Indra
7PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 29, 2025
The relationship between cancer risk and cystic fibrosis: the role of CFTR in cell growth and cancer development.Radek Indra, Věra Černá
|Sep 16, 2024
The tyrosine kinase inhibitor lenvatinib is oxidized by rat cytochromes P450 and affects their expression in rat liver.Radek Indra, Sandra Jelínková, Katarína Kollárová
|Aug 07, 2021
Benzo[<i>a</i>]pyrene-Induced Genotoxicity in Rats Is Affected by Co-Exposure to Sudan I by Altering the Expression of Biotransformation Enzymes.Helena Dračínská, Radek Indra, Sandra Jelínková
|Apr 30, 2021
Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib.Kateřina Jáklová, Tereza Feglarová, Simona Rex
|Dec 02, 2020
Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b<sub>5</sub> Activity.Radek Indra, Katarína Vavrová, Petr Pompach
|Jul 13, 2019
Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation.Radek Indra, Petr Pompach, Václav Martínek
Pageof 2
Frequent Collaborators
3 joint publications
Volker Manfred Arlt
2 joint publications
Marie Stiborová
2 joint publications
Katarína Vavrová
2 joint publications
Věra Černá
2 joint publications
Helena Dračínská
1 joint publications
Simon C Baker
1 joint publications
Josef Dvořák
1 joint publications
Peter Rubenwolf
1 joint publications
David H Phillips
1 joint publications
Jennifer Southgate
